• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对多种干预措施的模型的内部验证。

Internal validation of models with several interventions.

机构信息

Frankfurt School of Finance and Management, Sonnemannstr. 9-11, 60314, Frankfurt am Main, Germany,

出版信息

Eur J Health Econ. 2013 Dec;14(6):901-9. doi: 10.1007/s10198-012-0434-3. Epub 2012 Nov 3.

DOI:10.1007/s10198-012-0434-3
PMID:23124683
Abstract

In cost-effectiveness analyses, models are used typically to synthesize the best available data and/or extrapolate beyond clinical trial data. Ideally, models should be validated both internally and externally. The purpose of this paper is to suggest a test for internal validation of models where several interventions for the same clinical indication are compared. To the best of our knowledge, such a specific test does not yet exist. There are four versions of the test, which consider the relationship between incremental downstream costs and effects in the case of a single or several endpoints. We apply two versions of the validation test to published cost-effectiveness analyses of physical activity programs and demonstrate internal validity of the model in one study and lack of internal validity of the model in the other study.

摘要

在成本效益分析中,模型通常用于综合最佳现有数据和/或推断临床试验数据之外的信息。理想情况下,模型应进行内部和外部验证。本文的目的是提出一种针对模型内部验证的测试方法,该方法可用于比较针对同一临床适应证的多种干预措施。据我们所知,目前还没有专门针对这种情况的测试方法。该测试有四个版本,考虑了在单个或多个终点情况下增量下游成本和效果之间的关系。我们将验证测试的两个版本应用于已发表的体力活动计划成本效益分析,并证明了其中一项研究中的模型具有内部有效性,而另一项研究中的模型则缺乏内部有效性。

相似文献

1
Internal validation of models with several interventions.针对多种干预措施的模型的内部验证。
Eur J Health Econ. 2013 Dec;14(6):901-9. doi: 10.1007/s10198-012-0434-3. Epub 2012 Nov 3.
2
3
Dedicated Perioperative Hip Fracture Comanagement Programs are Cost-effective in High-volume Centers: An Economic Analysis.在高流量中心,专门的围手术期髋部骨折联合管理项目具有成本效益:一项经济分析。
Clin Orthop Relat Res. 2016 Jan;474(1):222-33. doi: 10.1007/s11999-015-4494-4. Epub 2015 Aug 11.
4
The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.促红细胞生成素(依泊汀和达贝泊汀)治疗癌症治疗引起的贫血的有效性和成本效益(包括对技术评估第142号的综述):系统评价和经济模型
Health Technol Assess. 2016 Feb;20(13):1-588, v-vi. doi: 10.3310/hta20130.
5
Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.开发和验证一个微观模拟经济模型,以评估与吸烟相关的疾病负担以及拉丁美洲烟草控制干预措施的成本效益。
Value Health. 2011 Jul-Aug;14(5 Suppl 1):S51-9. doi: 10.1016/j.jval.2011.05.010.
6
Exploring the cost-effectiveness of child dental caries prevention programmes. Are we comparing apples and oranges?探索儿童龋齿预防项目的成本效益。我们是在进行不恰当的比较吗?
Evid Based Dent. 2020 Mar;21(1):5-7. doi: 10.1038/s41432-020-0085-7.
7
A primer on cost-effectiveness analyses for vascular surgeons.血管外科医师的成本效益分析入门。
J Vasc Surg. 2012 Jun;55(6):1794-800. doi: 10.1016/j.jvs.2012.02.026.
8
Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure.心力衰竭患者管理干预措施经济分析工具:成本效益模型——一个基于网络的程序,旨在评估心力衰竭疾病管理项目的成本效益。
Am Heart J. 2015 Nov;170(5):951-60. doi: 10.1016/j.ahj.2015.08.015. Epub 2015 Aug 20.
9
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
10
Cost-effectiveness of supervised exercise therapy in heart failure patients.心力衰竭患者监督下运动疗法的成本效益。
Value Health. 2011 Jul-Aug;14(5 Suppl 1):S100-7. doi: 10.1016/j.jval.2011.05.006.

引用本文的文献

1
The price of curing cancer.治疗癌症的代价。
BMC Health Serv Res. 2021 Dec 11;21(1):1328. doi: 10.1186/s12913-021-07327-x.
2
Cost-Effectiveness Analysis of High-Efficiency Hemodiafiltration Versus Low-Flux Hemodialysis Based on the Canadian Arm of the CONTRAST Study.基于CONTRAST研究加拿大分支的高效血液滤过与低通量血液透析的成本效益分析
Appl Health Econ Health Policy. 2015 Dec;13(6):647-59. doi: 10.1007/s40258-015-0179-0.

本文引用的文献

1
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.避免和识别健康技术评估模型中的错误:定性研究和方法学综述。
Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250.
2
Cost-effectiveness of interventions to promote physical activity: a modelling study.促进身体活动干预措施的成本效益:一项建模研究。
PLoS Med. 2009 Jul 14;6(7):e1000110. doi: 10.1371/journal.pmed.1000110.
3
Adjusting life for quality or disability: stylistic difference or substantial dispute?
调整生活以提高质量还是减少残疾:是文体差异还是实质性争议?
Health Econ. 2009 Nov;18(11):1237-47. doi: 10.1002/hec.1424.
4
Cost effectiveness of community-based physical activity interventions.基于社区的体育活动干预措施的成本效益
Am J Prev Med. 2008 Dec;35(6):578-88. doi: 10.1016/j.amepre.2008.06.040.
5
Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers.使用BENESCO模拟模型对伐尼克兰与现有戒烟策略进行成本效用分析:应用于美国成年吸烟者群体
Pharmacoeconomics. 2008;26(6):497-511. doi: 10.2165/00019053-200826060-00004.
6
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.生活方式干预或二甲双胍在预防糖耐量受损成年人2型糖尿病方面的成本效益。
Ann Intern Med. 2005 Mar 1;142(5):323-32. doi: 10.7326/0003-4819-142-5-200503010-00007.
7
Review of guidelines for good practice in decision-analytic modelling in health technology assessment.卫生技术评估中决策分析模型良好实践指南综述。
Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. doi: 10.3310/hta8360.
8
Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.医疗保健评估中决策分析建模的良好实践原则:ISPOR良好研究实践——建模研究特别工作组报告
Value Health. 2003 Jan-Feb;6(1):9-17. doi: 10.1046/j.1524-4733.2003.00234.x.
9
Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness.资源匮乏地区宫颈癌筛查策略的政策分析:临床益处与成本效益
JAMA. 2001 Jun 27;285(24):3107-15. doi: 10.1001/jama.285.24.3107.
10
Compendium of physical activities: an update of activity codes and MET intensities.体力活动纲要:活动代码与代谢当量强度的更新
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504. doi: 10.1097/00005768-200009001-00009.